{"transactions":[{"id":1451585,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":88881,"kind":"person","name":"Austin Mark John","position":1,"cik":"0001713059","reported_name":"Austin Mark John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Finance/Prin Fin&Acct Offic"}}],"security":"Stock Option (right to buy)","published_at":"2024-07-19T11:36:52.000Z","date":"2024-07-17","kind":"grant","planned":false,"acquired":true,"shares":34500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests over four years with 1/48th of the shares subject to such option vesting and becoming exercisable in substantially equal monthly installments on the monthly anniversary after the Grant Date (07/17/2024), subject to a continued service relationship."}],"balance_after":34500,"derivative":{"exercise_price":11.96,"expiration_date":"2034-07-17","underlying":"Common Stock","underlying_shares":34500},"source":{"system":"sec-edgar","filing":"0000950170-24-084754","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/728387/000095017024084754/ownership.xml","form_type":"4"}},{"id":1536564,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":88881,"kind":"person","name":"Austin Mark John","position":1,"cik":"0001713059","reported_name":"Austin Mark John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Finance/Prin Fin&Acct Offic"}}],"security":"Stock option (right to buy)","published_at":"2024-04-24T20:35:11.000Z","date":"2024-04-23","kind":"exercise","planned":false,"acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Stock Option is fully vested."}],"balance_after":120000,"derivative":{"exercise_price":0.36,"expiration_date":"2032-08-09","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0000950170-24-047645","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/728387/000095017024047645/ownership.xml","form_type":"4"}},{"id":1536563,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":88881,"kind":"person","name":"Austin Mark John","position":1,"cik":"0001713059","reported_name":"Austin Mark John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Finance/Prin Fin&Acct Offic"}}],"security":"Common stock","published_at":"2024-04-24T20:35:11.000Z","date":"2024-04-23","kind":"exercise","planned":false,"acquired":true,"shares":30000,"price":0.36,"value":10800.0,"ownership":{"direct":true},"balance_after":84030,"source":{"system":"sec-edgar","filing":"0000950170-24-047645","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/728387/000095017024047645/ownership.xml","form_type":"4"}},{"id":1856675,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":88881,"kind":"person","name":"Austin Mark John","position":1,"cik":"0001713059","reported_name":"Austin Mark John","relationship":{"officer":true,"officer_title":"VP Finance/Prin Fin&Acct Offic"}}],"security":"Stock Options (right to buy)","published_at":"2023-06-14T20:45:36.000Z","date":"2023-06-12","kind":"grant","planned":false,"acquired":true,"shares":225000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% vested as of 6/12/2023, and the remaining 75% will vest over the next three (3) years, commencing on 6/12/2024, until fully vested."}],"balance_after":773115,"derivative":{"exercise_price":0.55,"expiration_date":"2033-06-12","underlying":"Common Stock","underlying_shares":225000},"source":{"system":"sec-edgar","filing":"0001437749-23-017422","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774923017422/rdgdoc.xml","form_type":"4"}},{"id":2188741,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":88881,"kind":"person","name":"Austin Mark John","position":1,"cik":"0001713059","reported_name":"Austin Mark John","relationship":{"officer":true,"officer_title":"VP Finance/Prin Fin&Acct Offic"}}],"security":"Stock Options (right to buy)","published_at":"2022-08-11T23:04:54.000Z","date":"2022-08-09","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% vested as of 8/9/2022, and the remaining 75% will vest over the next three (3) years, commencing on 8/9/2023, until fully vested."}],"balance_after":548115,"derivative":{"exercise_price":0.36,"expiration_date":"2032-08-09","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001437749-22-020203","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774922020203/rdgdoc.xml","form_type":"4"}},{"id":2238472,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":88881,"kind":"person","name":"Austin Mark John","position":1,"cik":"0001713059","reported_name":"Austin Mark John","relationship":{"officer":true,"officer_title":"VP Finance/Prin Fin&Acct Offic"}}],"security":"Common Stock","published_at":"2022-06-10T00:24:10.000Z","date":"2022-06-09","kind":"purchase","acquired":true,"shares":13800,"price":0.2869,"value":3959.22,"ownership":{"direct":true},"balance_after":54030,"source":{"system":"sec-edgar","filing":"0001437749-22-014723","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774922014723/rdgdoc.xml","form_type":"4"}},{"id":2238471,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":88881,"kind":"person","name":"Austin Mark John","position":1,"cik":"0001713059","reported_name":"Austin Mark John","relationship":{"officer":true,"officer_title":"VP Finance/Prin Fin&Acct Offic"}}],"security":"Common Stock","published_at":"2022-06-10T00:24:10.000Z","date":"2022-06-08","kind":"purchase","acquired":true,"shares":5000,"price":0.285,"value":1425.0,"ownership":{"direct":true},"balance_after":40230,"source":{"system":"sec-edgar","filing":"0001437749-22-014723","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774922014723/rdgdoc.xml","form_type":"4"}},{"id":2642961,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":88881,"kind":"person","name":"Austin Mark John","position":1,"cik":"0001713059","reported_name":"Austin Mark John","relationship":{"officer":true,"officer_title":"Controller/Prin Fin&Acct Offic"}}],"security":"Stock Options (right to buy)","published_at":"2021-07-06T20:31:12.000Z","date":"2021-07-01","kind":"grant","acquired":true,"shares":133500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% vested as of 7/1/2021, and the remaining 75% will vest over the next three (3) years, commencing on 7/1/2022, until fully vested."}],"balance_after":398115,"derivative":{"exercise_price":0.79,"expiration_date":"2031-07-01","underlying":"Common Stock","underlying_shares":133500},"source":{"system":"sec-edgar","filing":"0001437749-21-016456","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774921016456/rdgdoc.xml","form_type":"4"}},{"id":2999034,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":88881,"kind":"person","name":"Austin Mark John","position":1,"cik":"0001713059","reported_name":"Austin Mark John","relationship":{"officer":true,"officer_title":"Controller/Prin Fin&Acct Offic"}}],"security":"Warrant (right to buy)","published_at":"2020-10-28T20:46:26.000Z","date":"2020-10-22","kind":"purchase","acquired":true,"shares":9615,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Purchased pursuant to public offering that closed on October 22, 2020. Each share of common stock purchased included one-half of a warrant. Each whole warrant is exercisable to purchase one share of common stock at an exercise price of $0.57 per share. Each warrant is immediately exercisable, and will expire October 22, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Purchased pursuant to public offering that closed on October 22, 2020. Each share of common stock purchased included one-half of a warrant. Each whole warrant is exercisable to purchase one share of common stock at an exercise price of $0.57 per share. Each warrant is immediately exercisable, and will expire October 22, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Purchased pursuant to public offering that closed on October 22, 2020. Each share of common stock purchased included one-half of a warrant. Each whole warrant is exercisable to purchase one share of common stock at an exercise price of $0.57 per share. Each warrant is immediately exercisable, and will expire October 22, 2025."}],"balance_after":264615,"derivative":{"exercise_price":0.57,"exercise_date":"2020-10-22","expiration_date":"2025-10-22","underlying":"Common Stock","underlying_shares":9615},"source":{"system":"sec-edgar","filing":"0001437749-20-021861","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774920021861/rdgdoc.xml","form_type":"4"}},{"id":2999033,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":88881,"kind":"person","name":"Austin Mark John","position":1,"cik":"0001713059","reported_name":"Austin Mark John","relationship":{"officer":true,"officer_title":"Controller/Prin Fin&Acct Offic"}}],"security":"Common Stock","published_at":"2020-10-28T20:46:26.000Z","date":"2020-10-22","kind":"purchase","acquired":true,"shares":19230,"price":0.52,"value":9999.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Purchased pursuant to public offering that closed on October 22, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Purchased pursuant to public offering that closed on October 22, 2020."}],"balance_after":35230,"source":{"system":"sec-edgar","filing":"0001437749-20-021861","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774920021861/rdgdoc.xml","form_type":"4"}},{"id":3100373,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":88881,"kind":"person","name":"Austin Mark John","position":1,"cik":"0001713059","reported_name":"Austin Mark John","relationship":{"officer":true,"officer_title":"Controller/Prin Fin&Acct Offic"}}],"security":"Stock Options (right to buy)","published_at":"2020-06-25T20:46:55.000Z","date":"2020-06-23","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% vested as of 6/23/2020, and the remaining 75% will vest over the next three (3) years, commencing on 6/23/2021, until fully vested."}],"balance_after":255000,"derivative":{"exercise_price":0.61,"expiration_date":"2030-06-23","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001437749-20-013878","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774920013878/rdgdoc.xml","form_type":"4"}},{"id":3480716,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":88881,"kind":"person","name":"Austin Mark John","position":1,"cik":"0001713059","reported_name":"Austin Mark John","relationship":{"officer":true,"officer_title":"Controller/Prin Fin&Acct Offic"}}],"security":"Stock Options (right to buy)","published_at":"2019-06-24T20:56:34.000Z","date":"2019-06-18","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% vested as of 6/18/2019, and the remaining 75% will vest over the next three (3) years, commencing on 6/18/2020, until fully vested."}],"balance_after":225000,"derivative":{"exercise_price":0.43,"expiration_date":"2029-06-18","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001437749-19-012554","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774919012554/rdgdoc.xml","form_type":"4"}},{"id":3758175,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":88881,"kind":"person","name":"Austin Mark John","position":1,"cik":"0001713059","reported_name":"Austin Mark John","relationship":{"officer":true,"officer_title":"Controller/Prin Fin&Acct Offic"}}],"security":"Common Stock","published_at":"2018-11-21T00:21:34.000Z","date":"2018-11-16","kind":"purchase","acquired":true,"shares":4283,"price":0.3976,"value":1702.9208,"ownership":{"direct":true},"balance_after":16000,"source":{"system":"sec-edgar","filing":"0001437749-18-021156","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774918021156/rdgdoc.xml","form_type":"4"}},{"id":3764019,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":88881,"kind":"person","name":"Austin Mark John","position":1,"cik":"0001713059","reported_name":"Austin Mark John","relationship":{"officer":true,"officer_title":"Controller/Prin Fin&Acct Offic"}}],"security":"Common Stock","published_at":"2018-11-15T23:58:33.000Z","date":"2018-11-13","kind":"purchase","acquired":true,"shares":2452,"price":0.41,"value":1005.32,"ownership":{"direct":true},"balance_after":11717,"source":{"system":"sec-edgar","filing":"0001437749-18-020969","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774918020969/rdgdoc.xml","form_type":"4"}},{"id":3889974,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":88881,"kind":"person","name":"Austin Mark John","position":1,"cik":"0001713059","reported_name":"Austin Mark John","relationship":{"officer":true,"officer_title":"Controller/Prin Fin&Acct Offic"}}],"security":"Stock Options (right to buy)","published_at":"2018-06-20T00:29:02.000Z","date":"2018-06-13","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% vested as of 6/13/2018, and the remaining 75% will vest over the next three (3) years, commencing on 6/13/2019, until fully vested."}],"balance_after":175000,"derivative":{"exercise_price":0.46,"expiration_date":"2028-06-13","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001437749-18-012099","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774918012099/rdgdoc.xml","form_type":"4"}},{"id":4152071,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":88881,"kind":"person","name":"Austin Mark John","position":1,"cik":"0001713059","reported_name":"Austin Mark John","relationship":{"officer":true,"officer_title":"Controller/Prin Fin&Acct Offic"}}],"security":"Common Stock","published_at":"2017-11-24T22:16:31.000Z","date":"2017-11-24","kind":"purchase","acquired":true,"shares":1025,"price":0.49,"value":502.25,"ownership":{"direct":true},"balance_after":9265,"source":{"system":"sec-edgar","filing":"0001437749-17-019783","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774917019783/rdgdoc.xml","form_type":"4"}},{"id":4152070,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":88881,"kind":"person","name":"Austin Mark John","position":1,"cik":"0001713059","reported_name":"Austin Mark John","relationship":{"officer":true,"officer_title":"Controller/Prin Fin&Acct Offic"}}],"security":"Common Stock","published_at":"2017-11-24T22:16:31.000Z","date":"2017-11-24","kind":"purchase","acquired":true,"shares":515,"price":0.495,"value":254.925,"ownership":{"direct":true},"balance_after":8240,"source":{"system":"sec-edgar","filing":"0001437749-17-019783","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774917019783/rdgdoc.xml","form_type":"4"}},{"id":4152069,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":88881,"kind":"person","name":"Austin Mark John","position":1,"cik":"0001713059","reported_name":"Austin Mark John","relationship":{"officer":true,"officer_title":"Controller/Prin Fin&Acct Offic"}}],"security":"Common Stock","published_at":"2017-11-24T22:16:31.000Z","date":"2017-11-24","kind":"purchase","acquired":true,"shares":500,"price":0.495,"value":247.5,"ownership":{"direct":true},"balance_after":7725,"source":{"system":"sec-edgar","filing":"0001437749-17-019783","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774917019783/rdgdoc.xml","form_type":"4"}},{"id":4152068,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":88881,"kind":"person","name":"Austin Mark John","position":1,"cik":"0001713059","reported_name":"Austin Mark John","relationship":{"officer":true,"officer_title":"Controller/Prin Fin&Acct Offic"}}],"security":"Common Stock","published_at":"2017-11-24T22:16:31.000Z","date":"2017-11-22","kind":"purchase","acquired":true,"shares":1825,"price":0.49,"value":894.25,"ownership":{"direct":true},"balance_after":7225,"source":{"system":"sec-edgar","filing":"0001437749-17-019783","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774917019783/rdgdoc.xml","form_type":"4"}},{"id":4152067,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":88881,"kind":"person","name":"Austin Mark John","position":1,"cik":"0001713059","reported_name":"Austin Mark John","relationship":{"officer":true,"officer_title":"Controller/Prin Fin&Acct Offic"}}],"security":"Common Stock","published_at":"2017-11-24T22:16:31.000Z","date":"2017-11-21","kind":"purchase","acquired":true,"shares":3400,"price":0.485,"value":1649.0,"ownership":{"direct":true},"balance_after":5400,"source":{"system":"sec-edgar","filing":"0001437749-17-019783","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774917019783/rdgdoc.xml","form_type":"4"}},{"id":4152066,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":88881,"kind":"person","name":"Austin Mark John","position":1,"cik":"0001713059","reported_name":"Austin Mark John","relationship":{"officer":true,"officer_title":"Controller/Prin Fin&Acct Offic"}}],"security":"Common Stock","published_at":"2017-11-24T22:16:31.000Z","date":"2017-11-21","kind":"purchase","acquired":true,"shares":2000,"price":0.471,"value":942.0,"ownership":{"direct":true},"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001437749-17-019783","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774917019783/rdgdoc.xml","form_type":"4"}}]}